DMY Squared Tech (DMYY) Financials
Newest figures come from the 10-K for FY2025, filed Mar 18, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DMYY SEC filings page.
DMY Squared Tech (DMYY) reported $1.1M in revenue for fiscal year 2025, down 17.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Shrinking revenue is colliding with expanding overhead, while liabilities overwhelm the thin current-asset base.
In FY2025, the net loss reached-$17.8M while operating cash flow was only-$352K , indicating that noncash or non-operating items materially affected earnings. Operating cash flow improved from-$1.4M in FY2024 despite the deeper reported loss, making net income a poor standalone measure of cash demand.
Revenue fell
By FY2025, liabilities exceeded assets, reaching
Financial Health Signals
DMY Squared Tech does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
DMY Squared Tech passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
DMY Squared Tech reported a net loss of $17.8M while operations used $352K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
DMY Squared Tech held $78 in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
DMYY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q/A | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q/A |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $264K-23.6% | N/A | N/A | N/A | $346K-49.4% |
| SG&A Expenses | N/A | $2.0M+961.1% | $750K+225.6% | $521K+38.1% | N/A | $185K-23.2% | $230K+9.0% | $378K-28.8% |
| Operating Income | N/A | -$2.0M-590.8% | -$775K-87.7% | -$521K-12.9% | N/A | -$288K-19.6% | -$413K-64.1% | -$462K+24.3% |
| Income Tax | N/A | $65K-54.3% | $65K-71.7% | $37K-29.7% | N/A | $143K-10.8% | $232K+75.5% | $53K-65.2% |
| Net Income | N/A | -$931K-740.0% | -$6.4M-1885.6% | -$4.6M-2604.7% | N/A | $145K+299.5% | -$321K-126.9% | -$168K-132.0% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
DMYY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q/A | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q/A |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.4M+5.4% | $27.2M+6.4% | $26.9M+6.9% | $26.6M+2.6% | $26.0M-61.6% | $25.6M-61.8% | $25.2M-61.9% | $25.9M-60.6% |
| Current Assets | $112K-74.8% | $76K-81.2% | $212K-57.6% | $348K-52.3% | $442K+184.3% | $406K+28.5% | $500K+77.5% | $730K+94.6% |
| Cash & Equivalents | $78 | $6.9M+1693.7% | $4.7M+1057.8% | $3.7M+490.9% | N/A | $385K+4274100.0% | $406K+6765816.7% | $626K+51391.4% |
| Short-Term Investments | $0 | $0 | $0 | $0 | N/A | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | N/A | $0 | $0 | $0 |
| Total Liabilities | $54.4M+65.4% | $47.8M+51.9% | $46.2M+50.2% | $39.1M+23.8% | $32.9M-54.8% | $31.5M-56.3% | $30.8M-56.3% | $31.6M-55.4% |
| Current Liabilities | $8.3M+198.8% | $7.0M+166.6% | $4.9M+130.4% | $4.0M+56.8% | $2.8M+29.0% | $2.6M+81.3% | $2.1M+111.5% | $2.6M+153.2% |
| Non-Current Liabilities | $46.1M+53.1% | $40.9M+41.5% | $41.3M+44.2% | $35.1M+20.9% | $30.1M-57.4% | $28.9M-59.1% | $28.6M-58.8% | $29.0M-58.5% |
| Total Equity | -$27.0M-293.9% | -$20.7M-248.1% | -$19.3M-245.0% | -$12.5M-121.3% | -$6.8M-34.8% | -$5.9M-16.5% | -$5.6M-26.9% | -$5.6M-10.7% |
| Retained Earnings | -$27.0M-293.9% | -$20.7M-248.1% | -$19.3M-245.0% | -$12.5M-121.3% | -$6.8M-34.8% | -$5.9M-16.5% | -$5.6M-26.9% | -$5.6M-10.7% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
DMYY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q/A | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q/A |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $422K+660.1% | $1+100.0% | -$180+100.0% | -$774K-1190.1% | -$75K | -$21K-709333.3% | -$1.2M-241.4% | -$60K+74.7% |
| Investing Cash Flow | $48K+131.9% | -$150K0.0% | -$150K-117.3% | -$410K-101.0% | -$150K | -$150K | $869K+185.9% | $42.7M |
| Financing Cash Flow | -$470K-413.1% | $150K0.0% | $150K0.0% | $875K+102.1% | $150K | $150K | $150K+159.5% | -$42.0M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
DMYY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q/A | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q/A |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | -197.2% | N/A | N/A | N/A | -133.4% |
| Net Margin | N/A | N/A | N/A | -1723.1% | N/A | N/A | N/A | -48.7%-125.7pp |
| Return on Assets | N/A | -3.4%-4.0pp | -23.7%-22.4pp | -17.1%-16.5pp | N/A | 0.6%+0.7pp | -1.3%-3.1pp | -0.7%-1.4pp |
| Current Ratio | 0.01-0.1x | 0.01-0.1x | 0.04-0.2x | 0.09-0.2x | 0.16+0.1x | 0.16-0.1x | 0.240.0x | 0.28-0.1x |
| Asset Turnover | N/A | N/A | N/A | 0.010.0x | N/A | N/A | N/A | 0.010.0x |
Not reported in any period shown, so not listed: Gross Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$27.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| DMY Squared Tech DMYY | FY2025 | $1.1M | -$17.8M | N/A | $52.5M | — |
| AlphaVest Acquisition Corp ATMV | FY2025 | $6.0M | -$24.8M | N/A | $33.2M | 31/100 |
| Trailblazer Merger Corp I TBMC | FY2025 | N/A | -$8.3M | N/A | $18.0M | — |
| Eureka Acquisition Corp EURK | FY2025 | N/A | $1.4M | N/A | $25.2M | — |
| Horizon Space Acquisition I Corp. HSPO | FY2025 | N/A | $204K | N/A | $29.3M | — |
| Aimei Health Technology Co Ltd AFJK | FY2025 | N/A | $1.1M | N/A | $38.7M | — |
Where DMY Squared Tech Ranks
Frequently Asked Questions
What is DMY Squared Tech's annual revenue?
DMY Squared Tech (DMYY) reported $1.1M in total revenue for fiscal year 2025. This represents a -17.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is DMY Squared Tech's revenue growing?
DMY Squared Tech (DMYY) revenue declined by 17.6% year-over-year, from $1.3M to $1.1M in fiscal year 2025.
Is DMY Squared Tech profitable?
No, DMY Squared Tech (DMYY) reported a net income of -$17.8M in fiscal year 2025.
What is DMY Squared Tech's operating cash flow?
DMY Squared Tech (DMYY) recorded an outflow of $352K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are DMY Squared Tech's total assets?
DMY Squared Tech (DMYY) had $27.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is DMY Squared Tech's current ratio?
DMY Squared Tech (DMYY) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is DMY Squared Tech's return on assets (ROA)?
DMY Squared Tech (DMYY) had a return on assets of -65.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is DMY Squared Tech's debt-to-equity ratio negative or not reported?
DMY Squared Tech (DMYY) has negative shareholder equity of -$27.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is DMY Squared Tech's Piotroski F-Score?
DMY Squared Tech (DMYY) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are DMY Squared Tech's earnings high quality?
DMY Squared Tech (DMYY) reported a net loss of $17.8M while operations used $352K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.